SCHEMBL21133658

SCHEMBL21133658

CCCC1(C)CN(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51
OPRM1 P35372 9/20 0.50
OPRL1 P41146 9/20 0.50
OPRD1 P41143 8/20 0.50
OPRK1 P41145 8/20 0.50
CYP2D6 P10635 5/20 0.46
CYP3A4 P08684 5/20 0.46
CYP2C9 P11712 2/20 0.46
USP2 O75604 1/20 0.46
CYP1A2 P05177 1/20 0.46
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
DRD1 P21728 1/20 0.44
ADRA1D P25100 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691375 0.81 OPRL1 (0.60) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL8941915 0.81 OPRM1 (0.49) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL3153086 0.81 NPSR1 (0.53) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL9359047 0.79 NPSR1 (0.48) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL23366619 0.78 OPRM1 (0.49) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL10047375 0.77 NPSR1 (0.61) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL21639941 0.76 OPRL1 (0.74) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL20697774 0.75 CACNA2D1 (0.48) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL17049270 0.75 OPRM1 (0.56) NPSR1GPR55OPRM1OPRL1OPRD1
SCHEMBL8941983 0.75 NPSR1 (0.50) NPSR1GPR55OPRM1OPRL1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110816-B1 N2-PHENYL-PYRIDO[3,4-D]PYRIMIDINE-2,8-DIAMINE DERIVATIVES AND THEIR USE AS MPS1 INHIBITORS CANCER RESEARCH TECH LTD (GB) 2019-06-19 EP disclosed